Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight management.

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro pen, its widely used diabetes and weight-loss drug. Available in six dosages, Mounjaro helps manage type 2 ...

Eli Lilly's Mounjaro diabetes and weight-loss drug approved in India in KwikPen device, offering personalized treatment options.

Bernstein SocGen Group reaffirmed its Outperform rating and $1,100 price target for Eli Lilly & Company (NYSE:LLY) on June 13 ahead of the 85th Annual Meeting of the American Diabetes Association.

Eli Lilly announced late Saturday that its once-daily experimental pill, orforglipron, demonstrated significant efficacy in helping type 2 diabetes patients achieve both weight loss and lower blood ...

The epidemic increase in diabetes and its serious long-term consequences strongly support efforts to prevent its occurrence, with the expectation that morbidity and mortality will be decreased.

New diabetes drug may outperform Ozempic jab The first diabetes and obesity pill that works like Ozempic — but in tablet form — may actually outperform the injectables drugs.

The American Diabetes Association and the European Association for the Study of Diabetes provides a guide for doctors in choosing the most appropriate interventions for patients with type 2 diabetes.

Begin your week with a nutritious Greek yogurt parfait, combining protein-rich yogurt, antioxidant-packed berries, crunchy nuts, and honey for sweetness, offering energy and essential fats for ...